The USFDA inspected Shilpa Medicare Ltd's Finished Dosage Formulation Facility (Sterile and Non-sterile Dosage Forms) located at S-20 to S-26, Pharmaceutical Formulations SEZ, APIIC, Jadcherla (Telangana State) from 29th August to 6th September, 2019. The inspection concluded with two (2) observations. There were no repeat observations or Data Integrity (DI) related observations.
The company is confidence of addressing these observations and responding to the USFDA at the earliest.
Shares of SHILPA MEDICARE LTD. was last trading in BSE at Rs.258.6 as compared to the previous close of Rs. 244.65. The total number of shares traded during the day was 1908 in over 126 trades.
The stock hit an intraday high of Rs. 260.7 and intraday low of 225.15. The net turnover during the day was Rs. 478395.